Texas Yale Capital Corp’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,333
Closed -$30.1K 453
2024
Q1
$30.1K Hold
3,333
﹤0.01% 437
2023
Q4
$36.7K Hold
3,333
﹤0.01% 427
2023
Q3
$59.1K Hold
3,333
﹤0.01% 412
2023
Q2
$183K Hold
3,333
0.01% 420
2023
Q1
$227K Buy
3,333
+1,666
+100% +$130K 0.01% 414
2022
Q4
$101K Buy
1,667
+1,000
+150% +$93K 0.01% 438
2022
Q3
$67K Hold
667
﹤0.01% 438
2022
Q2
$59K Hold
667
﹤0.01% 436
2022
Q1
$101K Hold
667
0.01% 449
2021
Q4
$212K Hold
667
0.01% 428
2021
Q3
$299K Hold
667
0.02% 372
2021
Q2
$199K Buy
+667
New +$199K 0.01% 435

Other funds holding RBOT

Texas Yale Capital Corp's RBOT Position: Q2 2024 in Review

Texas Yale Capital Corp sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 3,333 shares — an estimated $30.1K sold.

Texas Yale Capital Corp first reported a position in RBOT in Q2 2021 and held it in 12 quarters. The position peaked at $299K in Q3 2021. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Texas Yale Capital Corp reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Texas Yale Capital Corp sold 3,333 Vicarious Surgical shares in Q2 2024, an estimated $30.1K.
  • Texas Yale Capital Corp first reported a position in Vicarious Surgical in Q2 2021 and held it in 12 quarters.
  • Texas Yale Capital Corp's Vicarious Surgical position peaked at $299K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Texas Yale Capital Corp's 13F filing for Q2 2024, filed 13 Aug 2024.